DEFINITIVE HEALTHCARE CORP (DH) Forecast, Price Target & Analyst Ratings
NASDAQ:DH • US24477E1038
1.18 USD
-0.04 (-3.28%)
At close: Mar 6, 2026
1.18 USD
0 (0%)
After Hours: 3/6/2026, 8:12:19 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DEFINITIVE HEALTHCARE CORP (DH).
Forecast Snapshot
Consensus Price Target
$3.98
+ 237.65% Upside
Next Earnings Forecast
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate$0.04
Revenue Estimate57.435M
ChartMill Buy Consensus
75.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.98
Upside
+ 237.65%
From current price of $1.18 to mean target of $3.98, Based on 20 analyst forecasts
Low
$2.78
Median
$3.83
High
$6.30
Price Target Revisions
1 Month
0.00%
3 Months
-3.68%
Price Target Summary
20 analysts have analysed DH and the average price target is 3.98 USD. This implies a price increase of 237.65% is expected in the next year compared to the current price of 1.18.
The average price target has been revised downward by 3.68% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
75.00%
DH was analyzed by 20 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about DH.
In the previous month the buy percentage consensus was at a similar level.
DH was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-27 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-27 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-12-09 | Barclays | Maintains | Underweight -> Underweight |
| 2025-11-10 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-08-08 | Stifel | Maintains | Buy -> Buy |
| 2025-05-12 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-04 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-03 | Barclays | Maintains | Underweight -> Underweight |
| 2025-01-16 | Needham | Reiterate | Hold -> Hold |
| 2025-01-13 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2024-12-20 | Stephens & Co. | Initiate | Equal-Weight |
| 2024-11-08 | Needham | Reiterate | Hold |
| 2024-09-17 | BTIG | Initiate | Buy |
| 2024-08-09 | Deutsche Bank | Maintains | Hold -> Hold |
| 2024-08-07 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-07 | Baird | Maintains | Neutral -> Neutral |
| 2024-08-06 | Needham | Reiterate | Hold |
| 2024-08-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-07-31 | Needham | Reiterate | Hold |
| 2024-07-31 | Stifel | Maintains | Buy -> Buy |
| 2024-07-31 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-07-31 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2024-07-31 | Baird | Maintains | Neutral -> Neutral |
| 2024-05-09 | Deutsche Bank | Maintains | Hold -> Hold |
| 2024-05-09 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate$0.04
Revenue Estimate57.435M
Revenue Q2Q-2.97%
EPS Q2Q-11.01%
Number of Analysts14
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.03%
EPS (1 Month)
0.00%
EPS (3 Months)
1.82%
Next Earnings Summary
DH is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.04 USD and the consensus revenue estimate is 57.44M USD.
The next earnings revenue estimate has been revised upward by 0.03% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 251.415M 12.89% | 252.202M 0.31% | 241.521M -4.24% | 232.26M -3.83% | 233.22M 0.41% | 248.3M 6.47% | |
| EBITDA YoY % growth | 20.839M 0.19% | 41.926M 101.19% | 35.527M -15.26% | 62.037M 74.62% | 64.375M 3.77% | 40.848M -36.55% | |
| EBIT YoY % growth | -30.911M 14.37% | -9.741M 68.49% | -20.583M -111.30% | 55.035M 367.38% | 57.493M 4.47% | N/A | |
| Operating Margin | -12.29% | -3.86% | -8.52% | 23.70% | 24.65% | N/A | |
| EPS YoY % growth | 0.30 25.00% | 0.35 16.67% | 0.25 -28.57% | 0.21 -16.10% | 0.23 9.88% | 0.25 7.26% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.04 -11.01% | 0.05 -23.34% | 0.07 1.53% | 0.07 20.17% | 0.07 62.04% | 0.07 34.36% | 0.07 1.45% | 0.07 |
| Revenue Q2Q % growth | 57.435M -2.97% | 57.713M -5.00% | 60.742M 1.16% | 61.115M -0.68% | 60.054M 4.56% | 61.352M 6.31% | 62.052M 2.16% | 63.057M 3.18% |
| EBITDA Q2Q % growth | 14.466M 92.44% | 15.309M -37.91% | 17.746M -57.86% | 18.478M -62.59% | 19.385M 34.00% | 19.668M 28.47% | 19.452M 9.61% | 22.49M 21.71% |
| EBIT Q2Q % growth | 11.262M 278.76% | 11.832M 438.25% | 15.118M 15,218.00% | 14.572M 317.01% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-0.37%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
0.24%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-11.92%
EBIT Next 5 Year
N/A
DEFINITIVE HEALTHCARE CORP / DH Forecast FAQ
What do analysts expect the price target to be for DEFINITIVE HEALTHCARE CORP (DH)?
20 analysts have analysed DH and the average price target is 3.98 USD. This implies a price increase of 237.65% is expected in the next year compared to the current price of 1.18.
Can you provide the upcoming earnings date for DEFINITIVE HEALTHCARE CORP?
DEFINITIVE HEALTHCARE CORP (DH) will report earnings on 2026-05-06.
Can you provide the consensus estimates for DEFINITIVE HEALTHCARE CORP next earnings?
The consensus EPS estimate for the next earnings of DEFINITIVE HEALTHCARE CORP (DH) is 0.04 USD and the consensus revenue estimate is 57.44M USD.
How many analysts have analysed DEFINITIVE HEALTHCARE CORP (DH)?
The number of analysts covering DEFINITIVE HEALTHCARE CORP (DH) is 20.